HappeningToo topic
Olanzapine Pamoate reports
Browse community reports connected to Olanzapine Pamoate. These reports can show that other people are describing similar experiences, but they do not prove that Olanzapine Pamoate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
28 problems
Abdominal Pain while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and abdominal pain appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and anxiety appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and back pain appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and constipation appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and decreased appetite appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and dehydration appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and diarrhea appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and dizziness appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and fatigue appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and feeling abnormal appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and headache appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and hypotension appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and insomnia appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and malaise appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and nausea appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and pain appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and peripheral swelling appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and rash appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Restlessness while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and restlessness appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and shortness of breath appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and sleepiness appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and tachycardia appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and tremor appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and vision blurred appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and vomiting appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and weakness appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and weight decreased appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Olanzapine Pamoate
FDA FAERS contains adverse-event reports in which Olanzapine Pamoate and weight increased appear together. This does not establish that Olanzapine Pamoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →